SHI Xuexia, MA Xiang, YE Xuelan. Intensive antiplatelet versus statin drugs in secondary prevention of high risk patients with ischemic stroke recurrence[J]. Journal of Clinical Medicine in Practice, 2018, (21): 1-4,8. DOI: 10.7619/jcmp.201821001
|
Citation:
|
SHI Xuexia, MA Xiang, YE Xuelan. Intensive antiplatelet versus statin drugs in secondary prevention of high risk patients with ischemic stroke recurrence[J]. Journal of Clinical Medicine in Practice, 2018, (21): 1-4,8. DOI: 10.7619/jcmp.201821001
|
SHI Xuexia, MA Xiang, YE Xuelan. Intensive antiplatelet versus statin drugs in secondary prevention of high risk patients with ischemic stroke recurrence[J]. Journal of Clinical Medicine in Practice, 2018, (21): 1-4,8. DOI: 10.7619/jcmp.201821001
|
Citation:
|
SHI Xuexia, MA Xiang, YE Xuelan. Intensive antiplatelet versus statin drugs in secondary prevention of high risk patients with ischemic stroke recurrence[J]. Journal of Clinical Medicine in Practice, 2018, (21): 1-4,8. DOI: 10.7619/jcmp.201821001
|
DownLoad: